DGIdb - DERSALAZINE Drug Record

DERSALAZINE chembl:CHEMBL2106406

Alternate Names:

UR-12746
DERSALAZINE

Drug Info:

FDA Approval	not approved
Drug Class	Small molecule
Drug Indications	antiinflammatory agent,for treatment of ulcerative colitis

(0 More Sources)

Publications:

Camuesco D et al., 2012, The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis., Br J Pharmacol

DERSALAZINE PTAFR

Interaction Score: 5.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
21790535

Sources:
TTD
DERSALAZINE PTGS1

Interaction Score: 0.25

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name dersalazine sodium

PMIDs:
None found

Sources:
TdgClinicalTrial
DERSALAZINE TNF

Interaction Score: 0.23

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dersalazine sodium

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial
DERSALAZINE PTGS2

Interaction Score: 0.19

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dersalazine sodium

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

TdgClinicalTrial: DERSALAZINE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications antiinflammatory agent,for treatment of ulcerative colitis

Drug Class Small molecule

FDA Approval not approved

Publications:

TTD: Dersalazine

Version: 2020.06.01

Alternate Names:

D0ZI0C TTD Drug ID

Drug Info:

Publications:

Camuesco D et al., 2012, The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis., Br J Pharmacol

ChemblDrugs: chembl:CHEMBL2106406
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

DERSALAZINE Drug Record

DERSALAZINE chembl:CHEMBL2106406

Alternate Names:

Drug Info:

Publications:

DERSALAZINE PTAFR

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
21790535

Sources:
TTD

DERSALAZINE PTGS1

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name dersalazine sodium

PMIDs:
None found

Sources:
TdgClinicalTrial

DERSALAZINE TNF

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dersalazine sodium

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

DERSALAZINE PTGS2

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dersalazine sodium

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

TdgClinicalTrial: DERSALAZINE

Alternate Names:

Drug Info:

Drug Indications antiinflammatory agent,for treatment of ulcerative colitis

Drug Class Small molecule

FDA Approval not approved

Publications:

TTD: Dersalazine

Alternate Names:

D0ZI0C TTD Drug ID

Drug Info:

Publications:

Camuesco D et al., 2012, The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis., Br J Pharmacol

ChemblDrugs: chembl:CHEMBL2106406

Alternate Names:

Drug Info:

Publications:

Novel drug target	Established target
Trial Name	dersalazine sodium

DERSALAZINE Drug Record

DERSALAZINE chembl:CHEMBL2106406

Alternate Names:

Drug Info:

Publications:

DERSALAZINE PTAFR

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 21790535

Sources: TTD

DERSALAZINE PTGS1

Interaction Types & Directionality: n/a

Interaction Info: Novel drug target Established target Trial Name dersalazine sodium

PMIDs: None found

Sources: TdgClinicalTrial

DERSALAZINE TNF

Interaction Types & Directionality: n/a

Interaction Info: Trial Name dersalazine sodium Novel drug target Established target

PMIDs: None found

Sources: TdgClinicalTrial

DERSALAZINE PTGS2

Interaction Types & Directionality: n/a

Interaction Info: Trial Name dersalazine sodium Novel drug target Established target

PMIDs: None found

Sources: TdgClinicalTrial

TdgClinicalTrial: DERSALAZINE

Alternate Names:

Drug Info: Drug Indications antiinflammatory agent,for treatment of ulcerative colitis Drug Class Small molecule FDA Approval not approved

Publications:

TTD: Dersalazine

Alternate Names: D0ZI0C TTD Drug ID

Drug Info:

Publications: Camuesco D et al., 2012, The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis., Br J Pharmacol

ChemblDrugs: chembl:CHEMBL2106406

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
21790535

Sources:
TTD

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name dersalazine sodium

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dersalazine sodium

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dersalazine sodium

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

Drug Info:

Drug Indications antiinflammatory agent,for treatment of ulcerative colitis

Drug Class Small molecule

FDA Approval not approved

Alternate Names:

D0ZI0C TTD Drug ID

Publications:

Camuesco D et al., 2012, The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis., Br J Pharmacol